(46 days)
Not Found
No
The description mentions "automatic software fiducial localization" and a "software component that reads the patient's Computed Tomography (CT) imaging series and determines the coordinate system". While this involves image processing and automation, there is no mention of AI, ML, deep learning, training data, or performance metrics typically associated with AI/ML algorithms. The focus is on a deterministic software process for fiducial localization within a defined coordinate system.
No.
The device is for localization and fixation during radiation therapy, not for providing the therapy itself.
No
Explanation: The device is used for patient localization and fixation during radiation therapy, not for diagnosing a medical condition. While it uses CT imaging data, it processes this data to determine coordinates for treatment delivery, not to identify diseases or abnormalities.
No
The device description explicitly states that the system includes both hardware and software components for localization and fixation. The software component works in conjunction with a hardware Stereotactic Fiducial Frame and other physical components.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs are used to examine specimens derived from the human body. The intended use and device description clearly state that this product is used for external beam stereotactic radiation therapy and radiosurgery of the head and neck and cranial regions. It is used on the patient for localization and fixation during imaging and treatment, not for analyzing biological samples taken from the patient.
- The device's function is related to patient positioning and localization for radiation therapy. It uses imaging data (CT scans) to determine the patient's position within a fiducial frame, which is crucial for accurate radiation delivery. This is a function related to medical imaging and treatment planning, not diagnostic testing of biological samples.
Therefore, this device falls under the category of a medical device used in radiation therapy, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
This product is used for patients who require external beam stereotactic radiation therapy of the head and neck region or radiosurgery of the cranial region. The system provides cranial and head and neck fixation and stereotactic localization with automatic software fiducial localization. It is intended to be used during both Computed Tomography (acquisition of the imaging series used for the patient's treatment plan) and each of the patient radiation treatments.
Product codes
IYE
Device Description
The Aktina Pinpoint Head and Neck Stereotactic Localizer, Part Number 50-100, is used for the localization and fixation of patients undergoing stereotactic radiotherapy and radiosurgery of the cranial area, as well as radiotherapy of the head and neck area. Fixation is accomplished via two components: a customized Dental Tray that with the aid of slight vacuum suction fixes to the roof of the patient's mouth, and a customized head and neck support. Localization is accomplished via two components: a hardware component which comprises of a Stereotactic Fiducial Frame that is positioned over the patient's treatment area while being accurately interfaced to the Dental Tray, and a software component that reads the patient's Computed Tomography (CT) imaging series and determines the coordinate system of the patient within the fiducial frame. The Fiducial Frames are used during the patient's initial CT and then as a setup target box for each treatment thereafter.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Computed Tomography (CT)
Anatomical Site
cranial area, head and neck area, head and neck region
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Hardware specification testing has been performed to show that the verification, validation and safety requirements have been met.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.5050 Medical charged-particle radiation therapy system.
(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
JAN 2 5 2011
510(k) Summary
In Compliance with 21 CFR Section 807.92(c)
1. General Provisions
| Device Trade Name: | Pinpoint Stereotactic Head and Neck Localizer |
|---|---|
| Common Name: | Head and Neck Fixation System |
| Owner Name | |
| and Address: | Aktina Medical Corporation |
| 360 North Route 9 W | |
| Congers, New York, 10920 | |
| Phone: 845-268-0101 | |
| Fax: 845-268-1700 | |
| Registration Number: 2436865 | |
| Contact Person: | Tony Spaccarotella |
| Date: | December 3 2010 |
2. Classification
This device is classified as class II according to 21 CFR 892.5050, "Medical charged-particle radiation therapy system." The product code is IYE.
3. Predicate Device
Stereotactic Head and Neck Localizer, K081935, manufactured by Aktina Medical Corporation, 360 North Route 9 W, Congers, New York, 10920
4. Description
The Aktina Pinpoint Head and Neck Stereotactic Localizer, Part Number 50-100, is used for the localization and fixation of patients undergoing stereotactic radiotherapy and radiosurgery of the cranial area, as well as radiotherapy of the head and neck area. Fixation is accomplished via two components: a customized Dental Tray that with the aid of slight vacuum suction fixes to the roof of the patient's mouth, and a customized head and neck support. Localization is accomplished via two components: a hardware component which comprises of a Stereotactic Fiducial Frame that is positioned over the patient's treatment area while being accurately interfaced to the Dental Tray, and a software component that reads the patient's Computed Tomography (CT) imaging series and determines the coordinate system of the patient within
1
the fiducial frame. The Fiducial Frames are used during the patient's initial CT and then as a setup target box for each treatment thereafter.
5. . Intended Use
This product is used for patients who require external beam stereotactic radiation therapy of the head and neck region or radiosurgery of the cranial region. The system provides cranial and head and neck fixation and stereotactic localization with automatic software fiducial localization. It is intended to be used during both Computed Tomography (acquisition of the imaging series used for the patient's treatment plan) and each of the patient radiation treatments.
6. Technological Characteristics
The Aktina Medical Pinpoint Stereotactic Head and Neck Localizer is identical to the predicate device, except that an additional source has been added for both the mouthpiece and its materials and the mouthpiece vacuum port is external to the patient rather than inside the mouth. The new mouthpiece and the original mouthpiece are otherwise identical in form, fit and function.
7. Performance Standards and Data
The FDA under Section 514 of the Food, Drug and Cosmetic Act has not established performance standards for this product
Hardware specification testing has been performed to show that the verification, validation and safety requirements have been met.
8. Biocompatibility
·
The Aktina Medical Corporation Pinpoint Stereotactic Head and Neck Localizer and its associated components, including the new mouthpiece, have been shown to be biocompatible per the requirements of the FDA's Blue Book Memorandum #G95-1, entitled Use of International Standard ISO-10993-1, "Biological Evaluation of Medical Devices Part 1: Evaluation and Testing" for surface devices in contact with the skin or a mucosal membrane with a contact duration of less than 24 hours.
9. Summary of Substantial Equivalence
This device is similar to the predicate device in design and intended use, as well as technological, physical, and performance characteristics. No new issues of safety or effectiveness are introduced by using this device.
.. .
2
Image /page/2/Picture/0 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a stylized eagle or bird symbol, with three curved lines representing its wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the bird symbol.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Mr. Tony Spaccarotella Director Quality Assurance/Regulatory Affairs Aktina Medical Corporation 360 North Route 9W CONGERS NY 10920
JAN 2 5 201
Re: K103616
Trade/Device Name: Pinpoint Stereotactic Head and Neck Localizer Regulation Number: 21 CFR 892,5050 Regulation Name: Medical charged-particle radiation therapy system Regulatory Class: II Product Code: IYE Dated: December 8, 2010 Received: December 10, 2010
Dear Mr. Spaccarotella:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition. FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
3
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours.
Mary Spatola
Mary Pastel, ScD. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
Section 4
Indications for Use
510(k) Number (if known):
Device Name: __ Pinpoint Stereotactic Head and Neck Localizer
Indications for Use:
This product is used for patients who require external beam stereotactic radiation therapy of the head and neck region or radiosurgery of the cranial region. The system provides cranial and head and neck fixation and stereotactic localization with automatic software fiducial localization. It is intended to be used during both Computed Tomography (acquisition of the imaging series used for the patient's treatment plan) and each of the patient radiation treatments.
Prescription Use V (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign Off)
510K. K103616